Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis

Blood (2024) 143 (14): 1399–1413.

https://doi.org/10.1182/blood.2023021349

Published: 2024

Includes: Supplemental data

Journal Articles

Evaluating the Performance of Large Language Models in Hematopoietic Stem Cell Transplantation Decision Making

Ivan Civettini, Arianna Zappaterra, Daniele Ramazzotti, Bianca Maria Granelli, Giovanni Rindone, Andrea Aroldi, Stefano Bonfanti, Federica Colombo, Marilena Fedele, Giovanni Grillo, Matteo Parma, Paola Perfetti, Elisabetta Terruzzi, Carlo Gambacorti-Passerini, Fabrizio Cavalca

Blood (2023) 142 (Supplement 1): 3726.

https://doi.org/10.1182/blood-2023-185854

Published: 2023

Journal Articles

First-Hit SETBP1 Mutations Cause a Myeloproliferative Disorder with Bone Marrow Fibrosis

Blood (2023) 142 (Supplement 1): 4135.

https://doi.org/10.1182/blood-2023-189094

Published: 2023

Journal Articles

Hemoglobin Monza: A New Variant of Unstable Hemoglobin

Ivan Civettini, Paola Corti, Arianna Zappaterra, Amedeo Messina, Andrea Aroldi, Andrea Biondi, Fabrizio Cavalca, Francesca Crosti, Giulia Maria Ferrari, Luca Mologni, Alberto Piperno, Daniele Ramazzotti, Alfonso Zambon, Fabio Rossi, Chiara Scollo, Carlo Gambacorti-Passerini

Blood (2023) 142 (Supplement 1): 5273.

https://doi.org/10.1182/blood-2023-184846

Published: 2023

Journal Articles

Targeting CD24 “Don't Eat Me” Signal Restores Phagocytic Activity of Nurse-like Cells from Patients with Chronic Lymphocytic Leukemia

Andrea Aroldi, Mario Mauri, Daniele Ramazzotti, Simone Piane, Matteo Villa, Federica Malighetti, Chiara Borella, Elisa Bossi, Federica Cocito, Carolina Steidl, Luca Mologni, Rocco Piazza, Carlo Gambacorti-Passerini

Blood (2023) 142 (Supplement 1): 4197.

https://doi.org/10.1182/blood-2023-190359

Published: 2023

Journal Articles

Preliminary Results of Phase 2 Open Label Study of Lorlatinib Monotherapy in Relapsed/Refractory ALK + Lymphomas Previously Treated with Other Tyrosine Kinase Inhibitors

Alessia Ripamonti, Andrea Aroldi, Federica Cocito, Luca Guerra, Lavinia Monaco, Bianca Maria Granelli, Lara Mussolin, Carlo Gambacorti-Passerini

Blood (2023) 142 (Supplement 1): 4474.

https://doi.org/10.1182/blood-2023-186702

Published: 2023

Journal Articles

Effects of CD24 "Don't Eat Me" Signal Blockade in Combination with Anti-CD47 and Rituximab in Mantle-Cell Lymphoma

Andrea Aroldi, Mario Mauri, Matteo Villa, Federica Malighetti, Federica Cocito, Claudia Voena, Roberto Chiarle, Luca Mologni, Rocco Piazza, Carlo Gambacorti-Passerini

Blood (2022) 140 (Supplement 1): 3136–3138.

https://doi.org/10.1182/blood-2022-159247

Published: 2022

Journal Articles

CD24/Siglec-10 "Don't Eat Me" Signal Blockade Is a Potential Immunotherapeutic Target in Mantle-Cell Lymphoma

Andrea Aroldi, Mario Mauri, Matteo Parma, Elisabetta Terruzzi, Marilena Fedele, Paola Perfetti, Federica Cocito, Luca Mologni, Roberto Chiarle, Rocco Piazza, Carlo Gambacorti-Passerini

Blood (2021) 138 (Supplement 1): 2276.

https://doi.org/10.1182/blood-2021-154086

Published: 2021

Journal Articles

Integrated Genomic, Functional and Prognostic Characterization of Atypical Chronic Myeloid Leukemia (aCML) in a Cohort of 43 Patients

Diletta Fontana, PhD, Daniele Ramazzotti, PhD, Andrea Aroldi, MD, Antonio Niro, MS, Luca Massimino, PhD, Delphine Rea, MD, Fabio Stagno, MD, Bruno Martino, MD, Leonardo Campiotti, MD, Giovanni Caocci, MD, Elena Maria Elli, MD, Monica Fumagalli, MD, Fabio Ciceri, MD, Rocco Piazza, MD PhD, Carlo Gambacorti-Passerini, MD

Blood (2019) 134 (Supplement_1): 1714.

https://doi.org/10.1182/blood-2019-126467

Published: 2019

Journal Articles

Central Nervous System Relapse in HIV Positive Patients Affected By Diffuse Large B Cell Lymphoma. IsÂ the CNS-IPI Score Useful in This Population?

Luisa Verga, MD, Davide Dalu, Rossella Renso, Andrea Aroldi, Ilaria De Benedetto, Filippo Brioschi, Claudia Zeroli, Paola Vitiello, Fulvio Crippa, Elisa Suardi, Raffaella Epifani, Omar Giglio, Maurizio Mena, Chiara Bombonati, Elisa Colella, Andrea Gori, Carlo Gambacorti-Passerini, MD, Alessandra Bandera

Blood (2017) 130 (Supplement 1): 1567.

https://doi.org/10.1182/blood.V130.Suppl_1.1567.1567

Published: 2017

Journal Articles

Imatinib Suspension and Validation (ISAV) Study: Results at 24 Months

Blood (2015) 126 (23): 2775.

https://doi.org/10.1182/blood.V126.23.2775.2775

Published: 2015

NARROW

First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis

Evaluating the Performance of Large Language Models in Hematopoietic Stem Cell Transplantation Decision Making

First-Hit SETBP1 Mutations Cause a Myeloproliferative Disorder with Bone Marrow Fibrosis

Hemoglobin Monza: A New Variant of Unstable Hemoglobin

Targeting CD24 “Don't Eat Me” Signal Restores Phagocytic Activity of Nurse-like Cells from Patients with Chronic Lymphocytic Leukemia

Preliminary Results of Phase 2 Open Label Study of Lorlatinib Monotherapy in Relapsed/Refractory ALK + Lymphomas Previously Treated with Other Tyrosine Kinase Inhibitors

Effects of CD24 "Don't Eat Me" Signal Blockade in Combination with Anti-CD47 and Rituximab in Mantle-Cell Lymphoma

CD24/Siglec-10 "Don't Eat Me" Signal Blockade Is a Potential Immunotherapeutic Target in Mantle-Cell Lymphoma

Integrated Genomic, Functional and Prognostic Characterization of Atypical Chronic Myeloid Leukemia (aCML) in a Cohort of 43 Patients

Central Nervous System Relapse in HIV Positive Patients Affected By Diffuse Large B Cell Lymphoma. IsÂ the CNS-IPI Score Useful in This Population?

Imatinib Suspension and Validation (ISAV) Study: Results at 24 Months

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only